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Abstract: Genetic engineering of viruses has generally been challenging. This is also true for
archaeal rod-shaped viruses, which carry linear double-stranded DNA genomes with hairpin ends.
In this paper, we describe two different genome editing approaches to mutate the Sulfolobus islandicus
rod-shaped virus 2 (SIRV2) using the archaeon Sulfolobus islandicus LAL14/1 and its derivatives
as hosts. The anti-CRISPR (Acr) gene acrID1, which inhibits CRISPR-Cas subtype I-D immunity,
was first used as a selection marker to knock out genes from SIRV2M, an acrID1-null mutant of
SIRV2. Moreover, we harnessed the endogenous CRISPR-Cas systems of the host to knock out the
accessory genes consecutively, which resulted in a genome comprised solely of core genes of the
11 SIRV members. Furthermore, infection of this series of knockout mutants in the CRISPR-null
host of LAL14/1 (∆arrays) confirmed the non-essentiality of the deleted genes and all except the
last deletion mutant propagated as efficiently as the WT SIRV2. This suggested that the last gene
deleted, SIRV2 gp37, is important for the efficient viral propagation. The generated viral mutants
will be useful for future functional studies including searching for new Acrs and the approaches
described in this case are applicable to other viruses.
Keywords: anti-CRISPR-based genome editing; selection marker; CRISPR-based genome editing;
core genome; accessory genes; essentiality; virus-host interaction
1. Introduction
Viruses are recognized as the most abundant biological entities on Earth. There are an estimated
1031 viruses on the planet [1] which outnumber their hosts by approximately tenfold in most
environments [2,3]. Metagenomics has shown the great diversity of viral communities. There are
possibly 500 different viral genotypes in 200 L of seawater and around one million different viral
genotypes in 1 kg of marine sediment [4]. However, viruses are still poorly understood with most of
their genes having an unknown function and showing little or no sequence similarity to genes
in databases [5]. Even though structural, transcriptomic, and proteomic studies have shed some
insight into the molecular mechanisms of the virus life cycle, efficient genetic manipulation is of great
importance to facilitate the functional characterization of many of these viral genes.
In general, genetic engineering of viruses is challenging. While non-lytic viruses can be
manipulated relatively easily by the introduction of a selection marker so that the host carrying
the recombinant viral genome survives the selection, for lytic viruses, only markers that are essential
for their propagation can be used for the genetic manipulation. For example, Escherichia coli trxA and
cmk genes are required for T7 phage propagation but not for host growth and they both can be used as
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markers for T7 phage engineering [6]. Only T7 phages that acquired the marker gene can propagate in a
host lacking the respective marker gene. However, these markers are scarce and only identified in a few
well-studied phages. To circumvent this, the Bacteriophage Recombineering of Electroporated DNA
(BRED) strategy was employed for the manipulation of lytic mycobateriophage [7,8]. In this case, BRED
phage DNA and a targeting template (either ssDNA or dsDNA with homologous arms flanking the
mutation sites of phage) are co-electroporated into a host. Furthermore, phage-derived recombinases
are exploited to induce high levels of homologous recombination between the phage genome and
the targeting template. However, this system is hard to use in strains refractory to electroporation.
For archaeal viruses, genetic engineering becomes even more crucial since they exhibit great genetic
diversity and only an extremely low percentage of their genes have detectable homologs in public
databases [9,10]. In previous studies, tedious methods such as long inverse PCR (LIPCR) [11–14],
transposon mutagenesis [11,14], or infectious clones [15] have been used for the construction of viral
mutants in Sulfolobus spindle-shaped virus (SSV) and Sulfolobus turreted icosahedral virus (STIV).
Both of these viruses have circular dsDNA genomes.
More recently, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their
associated genes (cas) systems have come into play. CRISPR-Cas constitutes a widely-spread adaptive
immune system in bacteria and archaea [16,17]. CRISPR loci consist of several cas genes and arrays of
short repeats separated by variable sequences originated from mobile genetic elements especially
viruses and plasmids. crRNAs expressed from the CRISPR arrays form effector complexes together
with Cas proteins, which guide them for invader silencing [18,19]. CRISPR-Cas systems especially
type II (Cas9) have been harnessed for genetic engineering of many organisms such as bacteria,
yeast, plants, and animals. In the first attempt, E. coli subtype I-E CRISPR-Cas system was used to
generate a deletion of two genes from T7 phage genome [20]. In addition, type II CRISPR-Cas system
has also been exploited for genetic manipulation of viruses. In one case, CRISPR-Cas9 was reported
to be a valuable tool for non-integrating adenoviral gene deletion and exchange [21]. Subtype II-A
CRISPR-Cas system from Streptococcus thermophiles was also used for point mutation, deletion, and
gene swap in Streptococcus phage 2972 [22].
In this scenario, we report on two different approaches for editing the genome of an archaeal virus
known as the Sulfolobus islandicus rod-shaped virus 2 (SIRV2), which carries a linear dsDNA of 35,498 bp
with covalently-closed ends and encodes 54 genes [23–25]. The first approach involves an anti-CRISPR
(Acr) protein as a selection marker while the second approach was marker-less by harnessing the host
endogenous CRISPR-Cas for editing. Acrs have been discovered in a number of viruses to date from
several narrow groups of bacteria and archaea such as Pseudomonas, Listeria, Streptococcus, Moraxella,
and Sulfolobus. Forty different families of Acr proteins have been found against CRISPR-Cas subtypes
I-C, I-D, I-E, I-F, II-A, II-C, and V-A [26–36], mostly by using a guilt-by-association bioinformatics
approach based on anti-CRISPR-associated genes [30]. AcrID1 (SIRV2 gp03 and SIRV3 gp02) is the first
example of Acr found in the archaea domain and the first against CRISPR-Cas type I-D system [29].
In this work, acrID1 was exploited as a selection marker to delete non-essential or essential genes in
the viral genome.
This research paper consists of two major parts. The first part involves gene knockout from
SIRV2M, an acrID1-null mutant of SIRV2 [29], using acrID1 (SIRV3 gp02) as a selection marker in
the Sulfolobus host carrying CRISPR-Cas type I-D immunity. In the second part, we knocked out
consecutively the accessary genes from another mutant of SIRV2 using a CRISPR-based genome
editing method and obtained a knockout mutant that carries only the core genome of the 11 SIRVs
known as SIRV1–SIRV11 [37]. The infectivity of the different viral mutants was also studied.
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2. Material and Methods
2.1. Strains and Growth Conditions
Sulfolobus islandicus LAL14/1 and its derivatives carrying pyrF deletion (∆pyrF) [38] and all five
CRISPR arrays deletion (∆arrays) [38] were used for infection and transformation. E. coli DH5α was
used for cloning of the plasmids.
Sulfolobus cells were grown aerobically at 78 ◦C and 150 rpm in a GCVY medium, which contains
basic salts medium [39] supplemented with 0.2% glucose, 0.2% casamino acids, 0.005% yeast extract,
and a vitamin mixture or SCV medium containing basic salts medium supplemented with 0.2%
sucrose, 0.2% casamino acids, and a vitamin mixture. Uracil (20 µg/mL) was added to the medium
for the cultivation of the ∆pyrF strains. Transformed E. coli cells were grown overnight at 37 ◦C in LB
(Luria–Bertani broth) agar supplemented with 100 µg/mL ampicillin. Single colonies were inoculated
into 20 mL of LB media supplemented with 100 µg/mL ampicillin and grown overnight at 37 ◦C and
200 rpm.
2.2. Cloning
All gene fragments were amplified by using PCR or fusion PCR with a Phusion Hot Start II
DNA Polymerase (2 U/µL) (F549L, Thermo Scientific™, Waltham, MA, USA) and primers listed
in Table S1. All primers and spacers were ordered as ssDNA (Integrated DNA Technologies, Inc.,
Coralville, IA, USA) and are listed in Table S1. PCR products were analyzed by using agarose gel
electrophoresis. PCR or digested products were purified using the GeneJET PCR Purification Kit
(K0702, Thermo Scientific™). Digested fragments and vectors were ligated using the T4 DNA ligase
kit (5 U/µL) (EL0011, Thermo Scientific™), according to the manufacturer’s instructions. The ligated
DNAs were transformed into E. coli DH5α, analyzed by colony PCR using Taq DNA Polymerase and
plasmid clones, which were purified using the Plasmid DNA Mini Kit I (D6943-02, Omega, Norcross,
USA). The inserts of the resultant clones were analyzed by using PCR, which was followed by DNA
sequencing (Eurofins Genomics, Ebersberg, Germany).
2.3. Construction of Anti-CRISPR-Based Genome Editing Plasmids
First, we constructed the pJET1.2 vectors with homologous flanking arms. Second, the acrID1
marker was digested with NheI and KpnI restriction enzymes (ER0971, ER0521, Thermo Scientific™)
and inserted between the homologous flanking arms in pJET1.2, which yielded pJET1.2 plasmids listed
in Table S1. SIRV2 gp49 was cloned into pEXA2 [40] for its expression.
2.4. Construction of CRISPR-Based Genome Editing Plasmids
CRISPR-based genome-editing plasmids (Table S1) were constructed individually by cloning a
mini-CRISPR array carrying a single spacer and a deletion mutant allele of the target gene into the
basic genome-editing plasmid pGE1 [38]. pGE1 contains LguI restriction sites that were oppositely
oriented and flanked by two CRISPR type I-A repeats as well as PaeI-XhoI restriction sites for the
insertion of homologous recombination sequences. crRNA generated from the mini-CRISPR array can
be used by type III effector complexes [41]. Additionally, for selective purposes, it contains a uracil
synthesizing gene [42].
First, a protospacer is identified in the gene of interest, which will be targeted by the CRISPR-Cas
immune system once the corresponding crRNA is provided. It is important to consider that type III
systems function only when the crRNA is complementary to a transcript. Under these circumstances,
a protospacer—39 nt long—on the template strand of the target gene was selected. Afterwards,
a spacer was constructed based on the selected protospacer of the target gene by mixing two
complementary oligonucleotides (Table S1), which was followed by heating at 95 ◦C for 10 min
and subsequently cooling down gradually to room temperature. The resulting dsDNA carrying 3 nt
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protruding ends—AAC and AGC—was ligated into the LguI site of the linearized pGE1 (FD1934,
Thermo Scientific™), which yielded plasmids carrying a mini-CRISPR array.
Respective donor DNA fragments containing the expected deletion mutant allele of each target
gene were obtained by using overlap extension PCR [43] from a SIRV2MII (Table 1) template.
The primers were designed for PCR amplification of two homologous DNA sequences (left and right
arms) flanking the target gene from the viral genome and, crucially, did not include the protospacer.
After fusion of both arms, the PCR products were digested with PaeI and XhoI restriction enzymes
(FD0604, FD0694, Thermo Scientific™) and purified again. In the case of target genes that are adjacent
in the genome—e.g., gp10, gp11, and gp12— a donor DNA was designed for the deletion of all of them
at a time. It is fundamental to consider maintaining intact promoters and terminators of neighboring
genes that might be within the target gene sequence. The resulting restriction DNA fragments were
inserted into their cognate mini-CRISPR array plasmids at the same site, which gave rise to pGE1
constructs listed in Table S1.
Table 1. SIRV2 and its derivative deletion mutants obtained in previous and present studies. The code
number associated to each deletion mutant is indicated. The deletion of the genes is shown in the order
at which they were obtained. The precise position of the deletions is indicated by using the SIRV2
genome as a reference. The size of the deletion is also shown.
Virus Position of NewDeletion (bp) Deletion Size (bp) Reference
SIRV2 - -
SIRV2M: ∆gp02–09,51–53 ∆1491–5474,∆32426–33939 3983, 1513 [29]
SIRV2MII: ∆gp02–09,51–53,48,10–14
∆30803-31479,
∆5678–8557 676, 2879
Bhoobalan-Chitty
unpublished
SIRV2MIII: ∆gp02–09,51–53,48,10–14,22–23 ∆12664–13395 731 This work
SIRV2MIV:
∆gp02–09,51–53,48,10–14,22–23,45–47 ∆29630–30517 888 This work
SIRV2MV:
∆gp02–09,51–53,48,10–14,22–23,45–47,50 ∆32169–32344 175 This work
SIRV2MVI:
∆gp02–09,51–53,48,10–14,22–23,45–47,50,29 ∆15827–16366 539 This work
SIRV2MVII:
∆gp02–09,51–53,48,10–14,22–23,45–47,50,29,37 ∆19910–20119 209 This work
2.5. Electroporation Procedure
Electroporation was used to transform S. islandicus with each pJET1.2-based or pGE1-based
construct, according to a procedure described previously [44], with the following modifications:
(1) all manipulations were carried out at room temperature, (2) after electroporation of 500 ng DNA
into 50 µL Sulfolobus competent cells (OD600 around 10), the cells were immediately transferred into
950 µL pre-warmed basic salts medium (pre-mixed with SIRV2M, MOI of 1, only in the case of pJET1.2
transformation) and incubated at 75 ◦C for 30 min without shaking, and (3) 100 µL of cells were mixed
with 5 mL of 2x SCV and 5 mL 0.4% Gelrite®and plated onto pre-warmed 1.4% Gelrite® (71010-52-1;
Roth) plates containing 2x SCV medium. After the top layer was set, the plates were put into a tightly
closed plastic box, and incubated at 78 ◦C for five to seven days.
2.6. Construction of Knockout Mutants and Knockout Screening by PCR
In the case of the CRISPR-based genome editing, the cells transformed with knockout plasmids
were grown in SCV medium (containing no uracil for the selection of the plasmids) and were infected
with the corresponding virus for genome editing. The cultures were grown from OD600 0.1 for 1 h and
infected with 10 µL of the previous deletion mutant for the next gene knockout. After 48 h of infection,
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viruses were harvested by centrifuging at 10,000× g for 6 min and the supernatant was diluted
106 times into fresh ∆arrays cells carrying the corresponding genome editing plasmid. The process
was repeated 4 to 5 times for complete removal of the WT virus.
All deletion mutants were screened by PCR amplification of the WT target gene and its mutated
allele by using primers listed in Table S1. The resulting PCR products were analyzed by agarose gel
electrophoresis and by DNA sequencing (Eurofins Genomics, Ebersberg, Germany).
2.7. Plaque Assay
Three mL of LAL14/1 ∆arrays cells (OD600 around 0.2) were premixed with serial dilutions of
the corresponding virus and incubated at 78 ◦C and 150 rpm for 30 min. The infected cultures were
then mixed with 3 mL of 0.4% Gelzan™ CM (Gelrite®, G1910, Merck KGaA, Darmstadt, Germany)
and plated onto pre-warmed 1.4% Gelzan plates containing 2x SCV medium. After the top layer
was set, the plates were put into a plastic box, tightly closed, and incubated at 78 ◦C for two days.
The observed circular zones of clearing (plaques) were due to viral replication and lysis of the Sulfolobus
host. The plaque forming units (PFU) were calculated from the plates containing a quantifiable
number of plaques.
3. Results and Discussion
3.1. Knockout of a Non-Essential Gene (SIRV2 Gp29) and an Essential Gene (SIRV2 Gp49) from SIRV2M
Genome Using AcrID1 as a Selection Marker
We reported recently that acrID1 flanked with recombination arms can be inserted into the SIRV2M
genome to evade the CRISPR-Cas I-D immunity [29]. In accordance, the first part of this work was to
test whether acrID1 could be used as a selection marker to knock out genes from the SIRV2M genome.
To this end, we randomly selected a non-essential gene (SIRV2 gp29) and an essential gene (SIRV2 gp49)
for the knockout [44,45].
The SIRV2 gp29, which is an ORF encoding 156 amino acids, is not part of the core genome of the
11 SIRV members known as SIRV1-SIRV11 (PMID:28534836) [37] and, thus, is likely to be non-essential
for viral propagation. As depicted in Figure 1A, a PCR product containing acrID1 flanked by the
upstream (495 bp) and downstream (441 bp) sequences of gp29 was cloned into the bacterial plasmid
pJET1.2, which does not replicate in S. islandicus. The plasmid was electroporated into LAL14/1 ∆pyrF,
which carries all the wild type CRISPR-Cas systems including the I-D immunity [38]. SIRV2M was
added immediately, which was followed by incubation at 78 ◦C for two days. Potential knockout of
gp29 through recombination between the homologous sequences of the plasmid and the SIRV2M
genome (Figure 1A) was monitored by PCR amplification of the SIRV2 gp29 region using virion DNA
in culture supernatant as a template, which revealed a substitution of gp29 with acrID1 (Figure 1B,
left panel). The culture supernatants were then diluted 1000 times into fresh LAL14/1 ∆pyrF cells and
PCR was performed again after two days of incubation (Figure 1B, right panel). This indicated that the
recombinant virus quickly became predominant and was maintained at a stable condition. To obtain
the pure gp29 deletion mutant (∆gp29), the culture supernatant was then diluted 1000 times into fresh
LAL14/1 ∆pyrF cells for two more rounds and the viral purity was checked by PCR amplification.
No band was detected with the primers located inside the gp29 gene indicating the high purity of
the mutant virus (Figure 1C). Thus, we succeeded to exploit acrID1 as a selection marker for the
knockout of an inessential gene.
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carrying SIRV2MΔgp29 (Δgp29). +, positive control using the SIRV2M virion as the PCR template, − 
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Next, we attempted to knock out an essential gene. SIRV2 gp49 (ORF98) encodes the only 
protein component of virus-associated pyramids (VAPs), which are assembled on the host cell 
surface and open up at the final stage of infection to facilitate the release of virus particles [46,47]. 
Accordingly, the VAP protein gp49 is considered to be essential for the lytic virus life cycle. In order 
to knock out this gene, we introduced a plasmid-borne gp49 into LAL14/1 ΔpyrF where gp49 was 
Figure 1. Knockout of the non-essential gene SIRV2 gp29 by using anti-CRISPR-based genome editing.
(A) Schematic illustration of the recombination (double crossover) between SIRV2M and acrID1
fragment (black arrow) cloned between the homologous arms (green and blue boxes) in pJET1.2. Genes
are depicted by arrows. F1/R1 primers, which are indicated by dark red arrows above the genome map,
amplify a region covering the deletion target while F2/R2, which is depicted in gold, amplify a region
within the deletion target (red arrow). (B) PCR analysis of the recombination events as depicted in (A)
where the size of PCR fragments is also indicated. Supernatants of the cultures containing the plasmid
(acrID1) two days post electroporation (left panel) and two days post dilution (1000 times into fresh
LAL14/1 ∆pyrF cells) (right panel) were used as a DNA template in the PCR reactions. Control 1, water
was electroporated into the cells but no SIRV2M was added. In control 2, water was electroporated
into the cells after the SIRV2M was added. The PCR bands derived from recombinant viruses are
labeled with white asterisks. (C) PCR verification of gene deletion in SIRV2M∆gp29 after two more
times dilution (1000 times into fresh LAL14/1 ∆pyrF cells). PCR was conducted with “∆gp29 check
primers” (Table S1) using supernatant from the culture carrying SIRV2M∆gp29 (∆gp29). +, positive
control using the SIRV2M virion as the PCR template, − as a negative control in “control 2” in (B),
L as a DNA size ladder.
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Figure 2. Knockout of the essential gene SIRV2 gp49 by using the anti-CRISPR-based genome editing.
(A) Right panel: schematic illustration of the recombination (double crossover) between SIRV2M and
acrID1 fragment (black arrow) cloned between the homologous arms (green and blue boxes) in pJET1.2.
Genes are depicted by arrows. F3/R3 primers, which are indicated by dark red arrows above the
genome map, amplify a region covering the deletion target while F4 (depicted in gold)/R3 amplify
a region from the deletion target (red arrow). The gp49-containing plasmid (pgp49, left panel) was
transformed into the cells prior to the knockout experiment. (B) PCR analysis of the recombination
events as depicted in (A) where the size of the PCR fragments is also indicated. Supernatants of
the cultures two days post electroporation with the acrID1-containing pJET1.2 plasmid (left panel)
and two days post dilution (1000 times into fresh LAL14/1 ∆pyrF/pgp49 cells) (right panel) were
used as the DNA template in the PCR reactions (acrID1). Control 1: water was electroporated into
the cells but no SIRV2M was added. Control 2: water was electroporated into the cells after which
SIRV2M was added. The PCR bands derived from recombinant viruses are labeled with white asterisks.
(C) PCR verification of gene deletion in SIRV2M∆gp49 after two more times dilution (1000 times into
fresh LAL14/1 ∆pyrF/pgp49 cells). PCR was conducted with “∆gp49 check primers” (Table S1) using
supernatant from SIRV2M∆gp49-containing cells (∆gp49). (+) positive control using SIRV2M virion as
the PCR template; −, negative control as “control 2” in (B) L, DNA size ladder.
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Next, we attempted to knock out an essential gene. SIRV2 gp49 (ORF98) encodes the only protein
component of virus-associated pyramids (VAPs), which are assembled on the host cell surface and
open up at the final stage of infection to facilitate the release of virus particles [46,47]. Accordingly,
the VAP protein gp49 is considered to be essential for the lytic virus life cycle. In order to knock out
this gene, we introduced a plasmid-borne gp49 into LAL14/1 ∆pyrF where gp49 was placed under the
control of a highly strong promoter known as the csa5 promoter from the host [48]. This ensures the
availability of enough VAP protein before the knockout takes place. The gp49-containing LAL14/1
∆pyrF cells (LAL14/1 ∆pyrF/pgp49) were then used to knock out gp49 from SIRV2M using the same
strategy that was applied to the previously mentioned knockout of gp29 (Figure 2A). As shown in
Figure 2B, the recombination between the acrID1-containing plasmid and SIRV2M genome was already
detectable two days post electroporation of the plasmid and the addition of SIRV2M in the culture
(left panel). Moreover, as with the gp29 knockout, the recombinant virus remained stable after a 1000
times dilution into fresh cultures (right panel). PCR involving one primer derived from the gp49
sequence demonstrated that a pure gp49 knockout viral strain (∆gp49) was obtained after two more
rounds of a 1000 fold dilution of the virus into fresh cultures (Figure 2C).
The infectivity of SIRV2M∆gp29 and SIRV2M∆gp49 were then tested in LAL14/1 ∆pyrF, which
carries the wild type CRISPR-Cas systems. Due to the insertion of acrID1, SIRV2M∆gp29 gained the
infectivity in LAL14/1 (Figure 3A), which also demonstrated the inessentiality of gp29. However, gp49
appeared to be essential for the lytic life cycle of the virus since SIRV2M∆gp49 is not able to cause
growth retardation of the host cells (Figure 3A) unless a plasmid-borne gp49 was provided (Figure 3B).
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3.2. CRISPR-Based Viral Genome Editing Approach
Even though the previously mentioned knockout approach is efficient, it leaves the selection
marker acrID1 in the recombinant viral genome, which makes it difficult for consecutive deletions of
other genes. Previously, CRISPR-Cas systems were harnessed for genome editing in the model
archaeon Sulfolobus [41], but, so far, no CRISPR-based genome editing approach has been applied to
archaeal viruses. Recently, SIRV2 gp48, which is a non-core gene of the 11 SIRVs, was deleted from
SIRV2M for a comprehensive functional study (Bhoobalan-Chitty et al., in preparation) from which we
initiated the CRISPR-based consecutive gene deletions.
The CRISPR-based viral genome editing procedure is depicted in Figure 4. First, two DNA
components were cloned into a plasmid. One is a mini-CRISPR array with a spacer targeting the gene
to be deleted and the other is a donor DNA with two homologous regions to the viral genome flanking
the target gene. Second, the plasmid was transformed into the CRISPR-null host of LAL14/1, ∆arrays,
and, therefore, the only crRNA is derived from the plasmid-borne mini-CRISPR array. Subsequently,
upon viral infection into the transformant, the viral DNA recombined with the donor DNA and the
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recombinant virus, which has gained a non-target allele, was selectively retained while the input virus
was killed due to the presence of a protospacer.Viruses 2018, 10, x FOR PEER REVIEW  9 of 17 
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3.3. Consecutive Knockout of SIRV2 Accessory Genes
A total of 23 genes have been identified as accessory genes in the SIRV2 genome on the basis that
they do not form part of the core genome of Sulfolobus islandicus rod-shaped viruses, which are known as
SIRV1-SIRV11 [37]. A 4 kb deletion in the left near-terminus spanning the SIRV2 gp02 to gp09 genes was
reported recently [29]. The resultant viral mutant, SIRV2M, carries another deletion of a 1.5 kb fragment
at the right near-terminus spanning the non-core gp51 to gp53 genes, which was revealed by PCR
amplification of this genomic region (Table 1). Consequently, after deletion of gp48 (Bhoobalan-Chitty,
in preparation), the viral genome was left with 11 accessory genes: gp10 (ORF105a), gp11 (ORF62a),
gp12 (ORF102), gp22 (ORF91), gp23 (ORF158b), gp29 (ORF156), gp37 (ORF114), gp45 (ORF94), gp46
(ORF95), gp47 (ORF112), and gp50 (ORF73). Eleven of the SIRVs core genes (black-colored arrows
in Figure 5) have no detectable homologs in the genome of the distant member of the Rudiviridae,
Acidianus rod-shaped virus (ARV) and five of these lack detectable homologs in another member
known as the Stygiolobus rod-shaped virus (SRV). This might be due to sequence divergence and were,
therefore, not considered for knockout. In addition, since gp25 (ORF76) is an ORF that overlaps gp26
and its expression is extremely low during the entire infection cycle [49,50], it might not be a gene and,
therefore, was not considered for knockout (white-colored arrows in Figure 5).
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In this part, we explored the CRISPR-based genome editing to knock out the accessory genes
one after another. After completion of a gene knockout, the resultant viral deletion mutant is infected
into a new host harboring a plasmid for the knockout of the next gene(s). To ensure the purity of the
knockout mutants, we diluted virions present in the culture supernatant 106-fold into fresh ∆arrays
cells carrying the corresponding genome editing plasmid. This process was repeated four to five
times. The knockout mutants were named according to the order they were generated from SIRV2M to
SIRV2MVII (Table 1).
Potential recombination events and the purity of the knockout mutants were monitored by PCR
amplification of the WT-target gene and its deletion mutant allele uses two sets of primers including
one annealing upstream and downstream of the target gene (F5/R5) and a second one annealing in the
genomic region within the target gene (F6/R6) (Figure 6A). As a result of the recombination between
the viral and the donor DNAs, the target gene is expected to be absent from the knockout mutant.
Therefore, the amplified fragments by F5/R5 primers would be shorter than that from the input virus
while the F6/R6 primer set would not be able to produce any amplicon. Additionally, subsequent DNA
sequencing of the PCR fragments allowed the determination of the precise positions of the deletions.
Figure 6B shows the results from PCRs performed using the last deletion mutant (“b” lanes)
SIRV2MVII (Table 1) as a template. SIRV2MII which is the starting virus used in this part of the work
(Table 1), was used as a positive control (“a” lanes) and water was used as a negative control (“c” lanes).
Despite the presence of some minor unspecific bands, all PCR generated major products as expected
(Table S2). The genes were knocked out in the following order: gp22–gp23, gp45–gp47, gp50, gp29, and
gp37 (Table 1), which were all shown to be present in SIRV2MII and absent in SIRV2MVII (Figure 6B).
The three genes, gp10-gp12, were supposed to be knocked out in the end, but we discovered, during
the knockout trial, that they were already absent from SIRV2MII and were still present in SIRV2M (“0”
lane in the last panel of Figure 6B). Moreover, gp13–gp14, which are part of the SIRVs core genome but
absent in ARV and SRV (Figure 5), were found to be absent in SIRV2MII as well (Table 1). It seems
that the deletion of gp10–gp14 naturally occurred as was the case for gp02–gp09 and gp51–gp53 in
SIRV2M [29]. The successive propagation of the virus in the CRISPR-null hosts, S. solfataricus 5E6 [50]
and S. islandicus LAL14/1 ∆arrays, could have promoted the loss of these near-terminus genes.
In order to check whether other spontaneous deletions had occurred in the smallest mutant
SIRV2MVII, five PCR fragments spanning the entire genome were amplified (Figure S1) and sequenced.
SIRV2MII was also sequenced as a control. Only a few single point mutations but no other gene
deletions were revealed (Table S3). The precise positions of the deletions using the SIRV2 genome as
a reference are detailed in Table 1. These were also supported by sequencing of the PCR products
derived from each knockout mutant using the respective primers F5/R5.
In all except one case, the knockout yielded the expected deletion. However, the deletion of
gp22–23 was different from what the donor DNA was designed to achieve. In this case, gp23 was not
completely deleted as expected, but, instead, 156 nt at the 5’ end was retained and, unexpectedly, 38 nt
at the 3’ end of gp21 was shown to be lost. Even though gp21 is a core gene of SIRVs, no obvious
homologs are present in ARV or SRV (Figure 5). It is, therefore, difficult to assess its essentiality.
Nevertheless, the deletion of the C-terminal 12 aa did not affect the viral life cycle since the knockout
mutant can still propagate in the CRISPR-null host (see below).
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Figure 6. Knockout of accessory genes from SIRV2MII by means of the CRISPR-based genome editing.
(A) Schematic diagram of the PCR strategy used for screening of mutated gene alleles. F5/R5 primers
—indicated by dark red arrows above the genome map—amplify a region covering the deletion
target while F6/R6—depicted in gold—amplify a region within the deletion target. Homologous
recombination with the donor DNA originates a deletion in the target gene by turning the input virus
(a) into a deletion mutant (b). Genes are indicated by block arrows. (B) PCR amplification of target gene
regions using the supernatant of infected cultures as a template. a, WT-target gene—SIRV2MII as a
template— b, deletion mutant allele—SIRV2MVII as a template— c, negative control—water instead of
virus template— 0, SIRV2M as a template. The corresponding amplified region is indicated on top of
the gel. DNA size ladders (L) with the sizes of selected bands are shown. Primers listed in Table S1
were used.
3.4. SIRVs’ Core Genome
After the natural and knockout deletions, the SIRV2 genome has been reduced in a total of
25 genes, which is something that translates into more than a 45% reduction in the gene content.
The resultant viral genome, SIRV2MVII, is 23849 kb in length, which is less than 70% of the original
genome size. Noteworthy, this points toward the notion that a large portion of viral genomes is
comprised merely of accessory genes, which are non-essential for their basic life cycle (grey-colored
arrows in Figure 5). Morons are additions [51]—more on them—that may optimize the phage to
adapt to a certain host or niche. Changing the combination of these genes gives the virus population
access to new niches.
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The remaining genes form the core genome of the 11 members of SIRVs, which are black and
color-coded in the genome maps in Figure 5 even though their essentiality remains to be tested
by experimental studies. Their average size is substantially larger than that of accessory genes.
A comparison between the smallest deletion mutant obtained in this work and representative
members of Rudiviridae family is depicted in Figure 5. The color-coded genes represent the core
genes shared by all the members of the family and it is reflected how they are essential for the lytic
cycle of the virus under any condition such as genes encoding the components for DNA replication,
nucleotide metabolism, and the assembly of the virus.
3.5. Assessing the Effect of The Deletions on Viral Infectivity
We compared the infectivity of SIRV2 and all the deletion mutants by infecting the CRISPR-null
host, ∆arrays, at a MOI of 0.1 and measuring the amount of virions released at 12 h and 24 h post
infection (hpi). Figure 7 shows a similar infectivity for SIRV2 and all the deletion mutants except
SIRV2MVII, which exhibited a tenfold reduction of the viral production. A repeated experiment using
SIRV2, SIRV2MII, and SIRV2MVII showed a similar result (Figure S2). In addition, the plaques formed
by SIRV2MVII were considerably smaller than those from SIRV2MVI and the other tested viruses
(Figure S3). Accordingly, it is inferred that the last gene deleted, gp37, is not essential but important for
the efficient propagation of the virus in the CRISPR-null host.
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Figure 7. Effect of the deletions on viral infectivity. ∆arrays cells were infected with SIRV2 and all
the deletion mutants individually at a MOI of 0.1 and the virus titer (PFU/mL) of the cultures were
measured with a plaque assay at 0, 12, and 24 hpi. Results from three technical replicates are shown and
error bars indicate the corresponding standard deviation of the mean for the three technical replicates.
PFU/mL is plotted in a logarithmic scale.
SIRV2 gp37 (ORF114) is homologous to proteins encoded by other crenarchaeal viruses including
double-stranded DNA genomes, which represent three viral families: Rudiviridae, Lipotrixviridae,
and Bicaudaviridae as well as the unclassified Sulfolobus turreted icosahedral virus (STIV). Homologs
are clearly identified on genomes of SIRV1 (gp29, ORF114) [23], SIRV3 (gp28, ORF114), Acidianus
filamentous viruses AFV1 (ORF116) [52] and AFV3 (gp16, ORF109) [53], STIV (ORFB116) [54], Sulfolobus
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monocaudavirus SMV4 (gp61, ORF113) [55], and S. islandicus filamentous virus SIFV (ORF118) [56].
STIV B116 and AFV3-109 have been identified as DNA binding proteins even though the DNA target
has not yet been identified [57,58]. Wirth et al. [15] showed that STIV B116 could be knocked out but
the resultant mutant exhibited smaller plaques and a delayed infection cycle, which indicates that the
null mutant is crippled. Despite DNA binding activity of STIV B116, the knockout mutant showed no
change in viral transcription patterns, which suggests that B116 is not a regulator of STIV transcription.
4. Conclusions
In this work, acrID1 was repurposed as a selection marker to genetically modify the SIRV2
genome including knocking out one essential gene. Moreover, using the CRISPR-based genome
editing approach, we successfully deleted all the remaining accessory genes of SIRV2, which yields
a viral genome formed solely by core genes of the 11 SIRV viruses. Both the Acr-based and the
CRISPR-based genome editing approaches were shown to be effective while the former required less
work in cloning and the latter lacked markers, which makes consecutive knockout possible. The results
provide a good basis for the future functional study of SIRV genes including the identification of
new Acrs. This work represents the first example of Acr-based and CRISPR-based viral genome
editing in the Archaea domain. The concept is applicable to other virus-host systems in both Bacteria
and Archaea.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/10/12/695/
s1, Figure S1: PCR amplification of five fragments spanning the entire viral genomes. Figure S2: Replicate for
plaquing efficiency assay assessing the effect of the deletions on viral infectivity. Figure S3: SIRV2MVII exhibits an
altered phenotype of small plaques, Table S1: Primer list. Table S2: Expected sizes (bp) from PCR amplification
presented in Figure 6. Table S3: Mutations identified in the genome of SIRV2MII and SIRV2MVII after whole
genome sequencing using primers listed in Table S1.
Author Contributions: Conceptualization, X.P., F.H., and Y.B.-C. Methodology, F.H. and Y.B.-C. Software, D.M.-M.
and F.H. Validation, X.P., F.H., Y.B.-C., and D.M.-M. Formal Analysis, D.M.-M., F.H., J.B.J., and P.K.M. Investigation,
D.M.-M., F.H., J.B.J., and P.K.M. Data Curation, D.M.-M. and F.H. Writing—Original Draft Preparation, D.M.-M.
and F.H. Writing—Review & Editing, X.P. and D.M.-M. Visualization, D.M.-M. and X.P. Supervision, X.P., Y.B.-C.,
and D.M.-M. Project Administration, X.P. Funding Acquisition, X.P.
Funding: This work was supported by the Danish Council for Independent Research/Technology and Production
(grant number DFF–7017-00060) and by the Novo Nordisk Foundation/Hallas-Møller Ascending Investigator
Grant (grant number NNF17OC0031154) to X.P. F.H was supported by China Scholarship Council.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Hendrix, R.W.; Lawrence, J.G.; Hatfull, G.F.; Casjens, S. The origins and ongoing evolution of viruses.
Trends Microbiol. 2000, 8, 504–508. [CrossRef]
2. Suttle, C.A. Marine viruses—Major players in the global ecosystem. Nat. Rev. Microbiol. 2007, 5, 801.
[CrossRef] [PubMed]
3. Edwards, R.A.; Rohwer, F. Opinion: Viral metagenomics. Nat. Rev. Microbiol. 2005, 3, 504. [CrossRef]
[PubMed]
4. Breitbart, M.; Rohwer, F. Here a virus, there a virus, everywhere the same virus? Trends Microbiol. 2005, 13,
278–284. [CrossRef] [PubMed]
5. Mateu, M.G. Structure and Physics of Viruses: An Integrated Textbook; Springer: Dordrecht, The Netherlands,
2013.
6. Qimron, U.; Marintcheva, B.; Tabor, S.; Richardson, C.C. Genomewide screens for Escherichia coli genes
affecting growth of T7 bacteriophage. Proc. Natl. Acad. Sci. USA 2006, 103, 19039–19044. [CrossRef]
[PubMed]
7. Marinelli, L.J.; Piuri, M.; Swigonˇová, Z.; Balachandran, A.; Oldfield, L.M.; van Kessel, J.C.; Hatfull, G.F.
BRED5: A simple and powerful tool for constructing mutant and recombinant bacteriophage genomes.
PLoS ONE 2008, 3, e3957. [CrossRef] [PubMed]
Viruses 2018, 10, 695 15 of 17
8. Marinelli, L.J.; Hatfull, G.F.; Piuri, M. Recombineering: A powerful tool for modification of bacteriophage
genomes. Bacteriophage 2012, 2, 5–14. [CrossRef]
9. Prangishvili, D.; Forterre, P.; Garrett, R.A. Viruses of the Archaea: A unifying view. Nat. Rev. Microbiol. 2006,
4, 837–848. [CrossRef]
10. Prangishvili, D.; Garrett, R.A.; Koonin, E.V. Evolutionary genomics of archaeal viruses: Unique viral genomes
in the third domain of life. Virus Res. 2006, 117, 52–67. [CrossRef]
11. Iverson, E.A.; Goodman, D.A.; Gorchels, M.E.; Stedman, K.M. Extreme Mutation Tolerance: Nearly Half of
the Archaeal Fusellovirus Sulfolobus Spindle-Shaped Virus 1 Genes Are Not Required for Virus Function,
Including the Minor Capsid Protein Gene vp3. J. Virol. 2017, 91, e02406–e02416. [CrossRef]
12. Clore, A.J.; Stedman, K.M. The SSV1 viral integrase is not essential. Virology 2007, 361, 103–111. [CrossRef]
[PubMed]
13. Iverson, E.; Stedman, K. A genetic study of SSV1, the prototypical fusellovirus. Front. Microbiol. 2012, 3.
[CrossRef] [PubMed]
14. Goodman, D.A.; Stedman, K.M. Comparative genetic and genomic analysis of the novel fusellovirus
Sulfolobus spindle-shaped virus 10. Virus Evol. 2018, 4, vey022. [CrossRef] [PubMed]
15. Wirth, J.F.; Snyder, J.C.; Hochstein, R.A.; Ortmann, A.C.; Willits, D.A.; Douglas, T.; Young, M.J.
Development of a genetic system for the archaeal virus Sulfolobus turreted icosahedral virus (STIV). Virology
2011, 415, 6–11. [CrossRef] [PubMed]
16. Barrangou, R.; Fremaux, C.; Deveau, H.; Richards, M.; Boyaval, P.; Moineau, S.; Romero, D.A.; Horvath, P.
CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315, 1709–1712. [CrossRef]
[PubMed]
17. Koonin, E.V.; Makarova, K.S.; Zhang, F. Diversity, classification and evolution of CRISPR-Cas systems.
Curr. Opin. Microbiol. 2017, 37, 67–78. [CrossRef] [PubMed]
18. Wiedenheft, B.; Sternberg, S.H.; Doudna, J.A. RNA-guided genetic silencing systems in bacteria and archaea.
Nature 2012, 482, 331. [CrossRef]
19. Garrett, R.A.; Vestergaard, G.; Shah, S.A. Archaeal CRISPR-based immune systems: Exchangeable functional
modules. Trends Microbiol. 2011, 19, 549–556. [CrossRef]
20. Kiro, R.; Shitrit, D.; Qimron, U. Efficient engineering of a bacteriophage genome using the type I-E
CRISPR-Cas system. RNA Biol. 2014, 11, 42–44. [CrossRef]
21. Bi, Y.; Sun, L.; Gao, D.; Ding, C.; Li, Z.; Li, Y.; Cun, W.; Li, Q. High-Efficiency Targeted Editing of Large Viral
Genomes by RNA-Guided Nucleases. PLoS Pathog. 2014, 10. [CrossRef]
22. Martel, B.; Moineau, S. CRISPR-Cas: An efficient tool for genome engineering of virulent bacteriophages.
Nucleic Acids Res. 2014, 43, 9504–9513. [CrossRef] [PubMed]
23. Prangishvili, D.; Arnold, H.P.; Götz, D.; Ziese, U.; Holz, I.; Kristjansson, J.K.; Zillig, W. A novel virus family,
the Rudiviridae: Structure, virus-host interactions and genome variability of the sulfolobus viruses SIRV1
and SIRV2. Genetics 1999, 152, 1387–1396. [PubMed]
24. Peng, X.; Blum, H.; She, Q.; Mallok, S.; Brügger, K.; Garrett, R.A.; Zillig, W.; Prangishvili, D. Sequences
and replication of genomes of the archaeal rudiviruses SIRV1 and SIRV2: Relationships to the archaeal
lipothrixvirus SIFV and some eukaryal viruses. Virology 2001, 291, 226–234. [CrossRef] [PubMed]
25. Martínez-Alvarez, L.; Bell, S.D.; Peng, X. Multiple consecutive initiation of replication producing novel
brush-like intermediates at the termini of linear viral dsDNA genomes with hairpin ends. Nucleic Acids Res.
2016, 44, 8799–8809. [CrossRef] [PubMed]
26. Pawluk, A.; Bondy-Denomy, J.; Cheung, V.H.W.; Maxwell, K.L.; Davidson, A.R. A new group of phage
anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of pseudomonas aeruginosa. mBio 2014, 5.
[CrossRef] [PubMed]
27. Marino, N.D.; Zhang, J.Y.; Borges, A.L.; Sousa, A.A.; Leon, L.M.; Rauch, B.J.; Walton, R.T.; Berry, J.D.;
Joung, J.K.; Kleinstiver, B.P.; et al. Discovery of widespread Type I and Type V CRISPR-Cas inhibitors. Science
2018, 362, 240–242. [CrossRef] [PubMed]
28. Bondy-Denomy, J.; Pawluk, A.; Maxwell, K.L.; Davidson, A.R. Bacteriophage genes that inactivate the
CRISPR/Cas bacterial immune system. Nature 2013, 493, 429–432. [CrossRef]
29. He, F.; Bhoobalan-Chitty, Y.; Van, L.B.; Kjeldsen, A.L.; Dedola, M.; Makarova, K.S.; Koonin, E.V.;
Brodersen, D.V.; Peng, X. Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D
immunity. Nat. Microbiol. 2018, 3, 461–469. [CrossRef]
Viruses 2018, 10, 695 16 of 17
30. Pawluk, A.; Staals, R.H.J.; Taylor, C.; Watson, B.N.J.; Saha, S.; Fineran, P.C.; Maxwell, K.L.; Davidson, A.R.
Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nat. Microbiol.
2016, 1. [CrossRef]
31. Rauch, B.J.; Silvis, M.R.; Hultquist, J.F.; Waters, C.S.; McGregor, M.J.; Krogan, N.J.; Bondy-Denomy, J.
Inhibition of CRISPR-Cas9 with Bacteriophage Proteins. Cell 2017. [CrossRef]
32. Hynes, A.P.; Rousseau, G.M.; Lemay, M.L.; Horvath, P.; Romero, D.A.; Fremaux, C.; Moineau, S.
An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9. Nat. Microbiol.
2017. [CrossRef] [PubMed]
33. Hynes, A.P.; Rousseau, G.M.; Agudelo, D.; Goulet, A.; Amigues, B.; Loehr, J.; Romero, D.A.; Fremaux, C.;
Horvath, P.; Doyon, Y.; Cambillau, C.; Moineau, S. Widespread anti-CRISPR proteins in virulent
bacteriophages inhibit a range of Cas9 proteins. Nat. Commun. 2018. [CrossRef] [PubMed]
34. Pawluk, A.; Amrani, N.; Zhang, Y.; Garcia, B.; Hidalgo-Reyes, Y.; Lee, J.; Edraki, A.; Shah, M.; Sontheimer, E.J.;
Maxwell, K.L.; Davidson, A.R. Naturally Occurring Off-Switches for CRISPR-Cas9. Cell 2016. [CrossRef]
[PubMed]
35. Lee, J.; Mir, A.; Edraki, A.; Garcia, B.; Amrani, N.; Lou, H.E.; Gainetdinov, I.; Pawluk, A.; Ibraheim, R.;
Gao, X.D.; Liu, P.; Davidson, A.R.; Maxwell, K.L.; Sontheimer, E.J. Potent Cas9 inhibition in bacterial and
human cells by new anti-CRISPR protein families. bioRxiv 2018. [CrossRef]
36. Watters, K.E.; Fellmann, C.; Bai, H.B.; Ren, S.M.; Doudna, J.A. Systematic discovery of natural CRISPR-Cas12a
inhibitors. Science 2018. [CrossRef] [PubMed]
37. Bautista, M.A.; Black, J.A.; Youngblut, N.D.; Whitaker, R.J. Differentiation and Structure in Sulfolobus
islandicus Rod-Shaped Virus Populations. Viruses 2017, 9, 120. [CrossRef] [PubMed]
38. He, F.; Vestergaard, G.; Peng, W.; She, Q.; Peng, X. CRISPR-Cas type I-A Cascade complex couples viral
infection surveillance to host transcriptional regulation in the dependence of Csa3b. Nucleic Acids Res. 2016,
45. [CrossRef] [PubMed]
39. Zillig, W.; Arnold, H.P.; Holz, I.; Prangishvili, D.; Schweier, A.; Stedman, K.; She, Q.; Phan, H.; Garrett, R.;
Kristjansson, J.K. Genetic elements in the extremely thermophilic archaeon Sulfolobus. Extremophiles 1998, 2,
131–140. [CrossRef]
40. Gudbergsdottir, S.; Deng, L.; Chen, Z.; Jensen, J.V.K.; Jensen, L.R.; She, Q.; Garrett, R.A. Dynamic properties of
the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid
genes and protospacers. Mol. Microbiol. 2011, 79, 35–49. [CrossRef]
41. Li, Y.; Pan, S.; Zhang, Y.; Ren, M.; Feng, M.; Peng, N.; Chen, L.; Liang, Y.X.; She, Q. Harnessing Type I and
Type III CRISPR-Cas systems for genome editing. Nucleic Acids Res. 2016, 44, e34. [CrossRef]
42. Peng, N.; Deng, L.; Mei, Y.; Jiang, D.; Hu, Y.; Awayez, M.; Liang, Y.; She, Q. A synthetic arabinose-inducible
promoter confers high levels of recombinant protein expression in hyperthermophilic archaeon Sulfolobus
islandicus. Appl. Environ. Microbiol. 2012. [CrossRef] [PubMed]
43. Horton, R.M.; Cai, Z.; Ho, S.N.; Pease, L.R. Gene splicing by overlap extension: Tailor-made genes using the
polymerase chain reaction. Biotechniques 2013. [CrossRef] [PubMed]
44. Deng, L.; Zhu, H.; Chen, Z.; Liang, Y.X.; She, Q. Unmarked gene deletion and host–vector system for the
hyperthermophilic crenarchaeon Sulfolobus islandicus. Extremophiles 2009, 13, 735–746. [CrossRef] [PubMed]
45. She, Q.; Zhang, C.; Deng, L.; Peng, N.; Chen, Z.; Liang, Y.X. Genetic analyses in the hyperthermophilic
archaeon Sulfolobus islandicus. Biochem. Soc. Trans. 2009. [CrossRef] [PubMed]
46. Quax, T.E.F.; Lucas, S.; Reimann, J.; Pehau-Arnaudet, G.; Prevost, M.-C.; Forterre, P.; Albers, S.-V.;
Prangishvili, D. Simple and elegant design of a virion egress structure in Archaea. Proc. Natl. Acad.
Sci. USA 2011. [CrossRef] [PubMed]
47. Bize, A.; Karlsson, E.A.; Ekefjärd, K.; Quax, T.E.F.; Pina, M.; Prevost, M.-C.; Forterre, P.; Tenaillon, O.;
Bernander, R.; Prangishvili, D. A unique virus release mechanism in the Archaea. Proc. Natl. Acad. Sci. USA
2009, 106, 11306–11311. [CrossRef] [PubMed]
48. He, F.; Chen, L.; Peng, X. First experimental evidence for the presence of a CRISPR toxin in Sulfolobus.
J. Mol. Biol. 2014. [CrossRef]
49. Quax, T.E.F.; Voet, M.; Sismeiro, O.; Dillies, M.; Jagla, B.; Coppee, J.-Y.; Sezonov, G.; Forterre, P.; van der
Oost, J.; Lavigne, R.; Prangishvili, D. Massive Activation of Archaeal Defense Genes during Viral Infection.
J. Virol. 2013, 87, 8419–8428. [CrossRef]
Viruses 2018, 10, 695 17 of 17
50. Okutan, E.; Deng, L.; Mirlashari, S.; Uldahl, K.; Halim, M.; Liu, C.; Garrett, R.A.; She, Q.; Peng, X. Novel
insights into gene regulation of the rudivirus SIRV2 infecting Sulfolobus cells. RNA Biol. 2013, 10, 875–885.
[CrossRef]
51. Juhala, R.J.; Ford, M.E.; Duda, R.L.; Youlton, A.; Hatfull, G.F.; Hendrix, R.W. Genomic sequences of
bacteriophages HK97 and HK022: Pervasive genetic mosaicism in the lambdoid bacteriophages. J. Mol. Biol.
2000. [CrossRef]
52. Bettstetter, M.; Peng, X.; Garrett, R.A.; Prangishvili, D. AFV1, a novel virus infecting hyperthermophilic
archaea of the genus Acidianus. Virology 2003. [CrossRef]
53. Haring, M.; Rachel, R.; Peng, X.; Garrett, R.A.; Prangishvili, D. Viral Diversity in Hot Springs of Pozzuoli,
Italy, and Characterization of a Unique Archaeal Virus, Acidianus Bottle-Shaped Virus, from a New Family,
the Ampullaviridae. J. Virol. 2005. [CrossRef] [PubMed]
54. Khayat, R.; Tang, L.; Larson, E.T.; Lawrence, C.M.; Young, M.; Johnson, J.E. Structure of an archaeal virus
capsid protein reveals a common ancestry to eukaryotic and bacterial viruses. Proc. Natl. Acad. Sci. USA
2005. [CrossRef] [PubMed]
55. Gudbergsdóttir, S.R.; Menzel, P.; Krogh, A.; Young, M.; Peng, X. Novel viral genomes identified from six
metagenomes reveal wide distribution of archaeal viruses and high viral diversity in terrestrial hot springs.
Environ. Microbiol. 2016. [CrossRef] [PubMed]
56. Arnold, H.P.; Zillig, W.; Ziese, U.; Holz, I.; Crosby, M.; Utterback, T.; Weidmann, J.F.; Kristjanson, J.K.;
Klenk, H.P.; Nelson, K.E.; Fraser, C.M. A novel lipothrixvirus, SIFV, of the extremely thermophilic
crenarchaeon Sulfolobus. Virology 2000. [CrossRef] [PubMed]
57. Larson, E.T.; Eilers, B.J.; Reiter, D.; Ortmann, A.C.; Young, M.J.; Lawrence, C.M. A new DNA binding protein
highly conserved in diverse crenarchaeal viruses. Virology 2007. [CrossRef]
58. Keller, J.; Leulliot, N.; Cambillau, C.; Campanacci, V.; Porciero, S.; Prangishvilli, D.; Forterre, P.; Cortez, D.;
Quevillon-Cheruel, S.; Van Tilbeurgh, H. Crystal structure of AFV3-109, a highly conserved protein from
crenarchaeal viruses. Virol. J. 2007. [CrossRef]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
